ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis' Gilenya staves off generic challengers—for now—after federal injunction
June 28, 2019Novartis’ multiple sclerosis med Gilenya is facing U.S. generic challengers on all sides to its blockbuster sales, and the company hoped a court order could stave them off. The Swiss drugmaker got what it asked for—and it might just keep the med at the to
Pharma Sources Insight January 2025
